---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-038598"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:22:50.384982+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Beauty Health CEO Andrew Stanleick departs; director Marla Beck named interim CEO

## Summary
- Andrew Stanleick steps down as CEO and board member effective Nov 19, 2023; will advise through Dec 31, 2023.
- Director Marla Beck appointed interim CEO from Nov 20, 2023, for a 6-month term; resigns from audit committee.
- Beck co-founded Bluemercury; led it as CEO for 22 years including post-acquisition by Macy's.
- Interim CEO compensation: $200K monthly base (min. 4 months), $500K RSUs ratably vesting over term, $400K change-in-control bonus.
- Board has initiated a formal search for a permanent CEO; Saunders expresses confidence in strategy and long-term growth.

## SEC filing metadata
- accession: 0001628280-23-038598
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/skin-20231110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-038598
- JSON: https://secwatch.observer/filing/0001628280-23-038598.json
- Plain text: https://secwatch.observer/filing/0001628280-23-038598.txt

## Key facts
- Executive change
  Andrew Stanleick departed as chief executive officer at SkinHealth Systems Inc..
  - Action: step down
  - Role: chief executive officer
  source text: Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm
- Executive change
  Marla Beck was appointed as interim chief executive officer at SkinHealth Systems Inc..
  - Action: appointed
  - Role: interim chief executive officer
  source text: the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Marla Beck, age 53, as interim chief executive officer of the Company (the “Interim CEO”), for a 6-month term (the “Term”) effective November 20, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023038598/0001628280-23-038598-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.